Home  /  Evidence

Proven in real-world care.

Docomed’s approach is grounded in deployed clinical programmes and long-standing clinical partnerships, not projections.

NHS Frimley ICS · remote monitoring

~6,000 high-risk patients monitored between visits

−53.7%hospital admissions
−38.6%A&E attendances
−36.3%999 emergency calls
−26.7%outpatient appointments
−19.4%GP contacts
−7.6%prescriptions

Continuous monitoring of high-risk patients turned a low-frequency snapshot into an early-warning signal, and moved activity out of the emergency pathway.

Atrial fibrillation · opportunistic screening

851 patients assessed at flu-vaccination clinics

137showed an irregular rhythm on assessment
28confirmed cases of atrial fibrillation
3cases of complete heart block needing urgent care
1 vs 21strokes at two years, assessed vs comparison group

Screening at a visit patients were already making, the same opportunistic model Docomed brings to routine primary care.

“I'm keen to support you in any way I can.”
Dr William E Cohn · Executive Director, Center for Device Innovation, Texas Medical Center

Clinical engagement

Working alongside leading clinicians.

Docomed is building its evidence base through partnerships with clinical innovators and active pilot programmes.

Device innovation

Dr William E Cohn

Director of the Center for Device Innovation at the Texas Medical Center, a supporter of Docomed's development and route into the TMC ecosystem.

Clinical pilot

Dr Reynolds Delgado, MD

Houston Methodist and Baylor St Luke's, running a clinical pilot across several clinics to capture cardiac data sets that strengthen the platform's machine-learning analytics.

Named clinical partners and quotations are shown with their permission; further validation from healthcare leaders will be added as programmes report.

Want the detail behind the numbers?

We’re happy to walk your clinical or evaluation team through the underlying data.